Lumiata, a San Mateo, CA—based provider of AI-powered health analytics for managing cost and risk, closed $11m in funding.
The round, which brought total funding to $31m, was co-led by Khosla Ventures and BlueCross BlueShield Venture Partners, with participation from Sandbox Industries, Intel Capital and others.
The company intends to use the funds to accelerate development of a new suite of predictive analytics products.
Led by CEO Dilawar Syed, Lumiata leverages clinical knowledge, data science and deep learning to provide predictive analytics for health plans, providers and self-insured employers to manage health costs. The company works with major U.S. health plans and providers.
Since its launch, Lumiata has developed models to predict disease risk and onset of certain chronic conditions for over 20 million patient lives. In the first half of 2018, the company has developed cost and spend prediction models with demonstrated improvement in prediction.